News
Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc. February 21, 2012 | Press Release
Biotech Dealmaking Gets off to a Strong Start in 2012 February 01, 2012 | Press Release
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
See all News
